Morgan Stanley’s Advanced Health Intelligence Ltd AHI Stock Holding History

Morgan Stanley’s Portfolio AHI Stock Details AHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,926	Closed	-$4.39K	–	8175
2024 Q2	$4.39K	Buy	2,926 +8	+0.3%	+$12	﹤0.01%	6878
2024 Q1	$4.38K	Sell	2,918 -118	-4%	-$213	﹤0.01%	6924
2023 Q4	$6.65K	Buy	3,036 +1,928	+174%	+$3.95K	﹤0.01%	6939
2023 Q3	$2.77K	Buy	1,108 +108	+11%	+$407	﹤0.01%	7058
2023 Q2	$3.83K	Buy	1,000 +250	+33%	+$564	﹤0.01%	7042
2023 Q1	$1.1K	Sell	750 -600	-44%	-$1.09K	﹤0.01%	7341
2022 Q4	$2.21K	Sell	1,350 -1,127	-45%	-$1.96K	﹤0.01%	7347
2022 Q3	$6K	Buy	2,477 +302	+14%	+$799	﹤0.01%	7236
2022 Q2	$5K	Sell	2,175 -75	-3%	-$278	﹤0.01%	7433
2022 Q1	$14K	Buy	+2,250	New	+$18.9K	﹤0.01%	7301

Other funds holding AHI

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Morgan Stanley's AHI Position: Q3 2024 in Review

Morgan Stanley sold out of Advanced Health Intelligence Ltd (AHI) in Q3 2024, closing a stake of 2,926 shares — an estimated $4.39K sold.

Morgan Stanley first reported a position in AHI in Q1 2022 and held it in 10 quarters. The position peaked at $14K in Q1 2022. 1 fund tracked by Wall St. Rank holds AHI as of Q3 2024.

Morgan Stanley reported no remaining Advanced Health Intelligence Ltd position as of Q3 2024 after selling out during the quarter.
Morgan Stanley sold 2,926 Advanced Health Intelligence Ltd shares in Q3 2024, an estimated $4.39K.
Morgan Stanley first reported a position in Advanced Health Intelligence Ltd in Q1 2022 and held it in 10 quarters.
Morgan Stanley's Advanced Health Intelligence Ltd position peaked at $14K in Q1 2022.
1 fund tracked by Wall St. Rank held Advanced Health Intelligence Ltd as of Q3 2024.

Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.